Related Experiment Video
Updated: Jan 16, 2026
05:04
Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training
Published on: August 9, 2024
1.4K
Gaps in Pediatric Interventional Cardiology Technology: A Survey Assessment
Daniel Levi1, Nicholas Sharawy1, Tim Moran2
1Division of Pediatric Cardiology, Mattel Children's Hospital at UCLA, Los Angeles, USA.
Pediatric Cardiology
|October 3, 2025
Summary
Pediatric interventional cardiologists need new devices like biodegradable stents and PDA stents. This 2024 survey guides development for critical congenital heart disease interventions.
Area of Science:
- Pediatric Cardiology
- Medical Device Development
- Congenital Heart Disease
Background:
- A 2015 survey identified device needs for pediatric congenital interventional cardiologists.
- An updated survey was conducted in 2024 to reassess these needs.
Purpose of the Study:
- To evaluate current gaps in device and equipment availability for pediatric congenital interventional cardiologists.
- To identify the most pressing needs for new interventional devices.
Main Methods:
- An online survey was distributed to over 200 US pediatric interventional cardiologists.
- The survey was disseminated through the Congenital Cardiovascular Interventional Study Consortium (CCISC) and the Pediatric and Congenital Interventional Cardiovascular Society (PICS).
Main Results:
- Biodegradable Stents (37%), PDA Stents (21%), and Pulmonary Artery Flow Restrictors (21%) were the top three most needed devices.
- Flow Restrictors (30%), PDA Stents (18%), and Biodegradable Stents (6%) were identified as devices with the greatest potential to reduce mortality.
- Respondents prioritized devices not available in the US or removed from the market.
Conclusions:
- The 2024 survey revealed significantly different device needs compared to 2015.
- Survey results aim to guide tailored device development for the congenital interventional cardiology community.
- Addressing these identified needs is crucial for improving outcomes in pediatric congenital interventions.
Keywords:
Biodegradable stentCongenital interventional cardiologyPDA deviceTranscatheter device, Pediatric medical devicesMore Related Videos
Related Concept Videos
01:28Cardiac Catheterization I: Pre-Procedure Overview
1.1K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.1K
01:21Cardiac Catheterization II: Right Heart Catheterization
811
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
811
01:24Cardiac Catheterization III: Left Heart Catheterization
577
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
577
01:26Cardiac Catheterization IV: Nursing Management
644
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
644
01:27Assessment of the Cardiovascular System III: Palpation
1.0K
Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
1.0K
01:29Cardiomyopathy V: Interprofessional Care
338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338